|
Thermo Fisher Scientific is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.〔(【引用サイトリンク】title=Pierce Antibodies )〕〔(【引用サイトリンク】title=Fisher Scientific )〕 In April 2013, after a competitive bidding with Hoffmann-La Roche,〔Z. Brennan (March 2013). (Price of Life Tech Steady at $11B as Roche Joins Bidding War )〕 Thermo Fisher acquired Life Technologies Corp for $13.6 billion in a deal that would rank the firm as one of the leading companies in the genetic testing and precision laboratory equipment markets.〔(【引用サイトリンク】title=Equipamentos e produtos para laboratórios - Analítica )〕〔http://fisherhealthcare.dirxion.com〕 ==Predecessors and merger== Thermo Electron was co-founded in 1956 by George N. Hatsopoulos and Peter M Nomikos. Hatsopoulos is a MIT PhD in mechanical engineering and Nomikos a Harvard Business School graduate.〔http://web.mit.edu/newsoffice/founders/Thermo.html Company founding〕 It focused on providing analytical and laboratory products and services, and had revenues of over $2 billion in 2004.〔(【引用サイトリンク】title=Financial Statements for Thermo Fisher Scientific Inc. - Google Finance )〕 Fisher Scientific was founded in 1902 by Chester G. Fisher from Pittsburgh.〔http://www.shadysidepres.org/sites/default/files/2013_04_07_bulletin.pdf〕〔(【引用サイトリンク】title=PPG Vice President Fisher Dies. )〕 It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education.〔(Thermo Fisher Scientific : Corporate Profile )〕 On May 14, 2006, Thermo Electron and Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange; the merged company was named Thermo Fisher Scientific.〔(Merger of Thermo Electron and Fisher Scientific Completed, Forming Thermo Fisher Scientific ), press release, November 9, 2006〕 On November 9, 2006, the companies announced that the merger had been completed.〔 However, the Federal Trade Commission ruled that this acquisition was anticompetitive with regard to centrifugal evaporators, requiring Fisher to divest Genevac.〔(Merger of Thermo and Fisher anticompetitive ), FTC Ruling〕 In April 2007, Genevac was sold to Riverlake Partners LLC〔3 April 2007. (Riverlake Partners, LLC Acquires UK-based Genevac, Ltd. ) Press Release.〕 and the merger closed with FTC approval.〔(FTC consent to Genevac divestiture ), FTC news release〕 Currently, the company's products are sold under the brand names of Thermo Scientific, Fisher Scientific, and several other recognized brand names (e.g. Chromacol, Nalgene, Cellomics, Pierce Protein Research and Fermentas). According to company figures, 46% of its sales are in life sciences, 20% in healthcare, and 34% in industrial/environmental and safety.〔 Thermo Fisher has offices and operations in many countries, notably the U.S. and in Europe. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand in testing for allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash purchase. In 2013 Thermo Fisher agreed to buy Life Technologies for $13.6 billion. The sale was completed on 4 February 2014, and the Life Technologies brand became part of the Life Sciences Solutions Group of Thermo Fisher Scientific. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs, manufactures and delivers technologies used in bioprocessing solutions.〔(【引用サイトリンク】title=Thermo Fisher Scientific Acquires Single-Use Specialist ASI for $300 Million - GEN News Highlights - GEN )〕 In June 2015, the company announced its intention to acquire Alfa Aesar, a global manufacturer of research chemicals for $405 million.〔(【引用サイトリンク】title=Thermo Fisher Scientific Agrees to Acquire Research Chemicals Firm )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Thermo Fisher Scientific」の詳細全文を読む スポンサード リンク
|